Which intravesical chemotherapeutic agents are used in the treatment of bladder carcinoma in situ?

Updated: Oct 24, 2019
  • Author: Stanley A Brosman, MD; Chief Editor: Bradley Fields Schwartz, DO, FACS  more...
  • Print


Chemotherapeutic agents that can be administered intravesically to treat carcinoma in situ (CIS) include the following:

  • Mitomycin-C

  • Gemcitabine

  • Doxorubicin

  • Valrubicin

  • Thiotepa

  • Cisplatin

No evidence suggests that these adjuvant therapies are as effective as bacillus Calmette-Guérin (BCG). These agents may increase the time to disease recurrence, but no evidence indicates that they prevent disease progression.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!